Bone Morphogenetic Protein Receptor-2 and Pulmonary Arterial Hypertension
- 27 May 2005
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 96 (10) , 1033-1035
- https://doi.org/10.1161/01.res.0000168922.54339.47
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial HypertensionCirculation Research, 2005
- Pathogenesis of Pulmonary Arterial HypertensionCirculation, 2005
- Pulmonary Hypertension in Transgenic Mice Expressing a Dominant-Negative BMPRII Gene in Smooth MuscleCirculation Research, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Suppression of Tumor Necrosis Factor-mediated Apoptosis by Nuclear Factor κB-independent Bone Morphogenetic Protein/Smad SignalingPublished by Elsevier ,2001
- Bone Morphogenetic Protein-2 Inhibits Serum Deprivation-induced Apoptosis of Neonatal Cardiac Myocytes through Activation of the Smad1 PathwayJournal of Biological Chemistry, 2001
- Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertensionThe FASEB Journal, 2001
- Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta familyJournal of Medical Genetics, 2000
- Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.Journal of Clinical Investigation, 1998